- Home
- ANVS vs BRNS Comparison
ANVS vs BRNS Comparison
Compare ANVS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- BRNS
- Stock Information
- Founded
- ANVS 2008
- BRNS 2016
- Country
- ANVS United States
- BRNS United Kingdom
- Employees
- ANVS N/A
- BRNS N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ANVS Health Care
- BRNS Health Care
- Exchange
- ANVS Nasdaq
- BRNS Nasdaq
- Market Cap
- ANVS 55.5M
- BRNS 54.1M
- IPO Year
- ANVS 2020
- BRNS 2021
- Fundamental
- Price
- ANVS $2.74
- BRNS $1.24
- Analyst Decision
- ANVS Strong Buy
- BRNS Strong Buy
- Analyst Count
- ANVS 4
- BRNS 1
- Target Price
- ANVS $18.00
- BRNS $3.00
- AVG Volume (30 Days)
- ANVS 277.6K
- BRNS 238.3K
- Earning Date
- ANVS 08-12-2025
- BRNS 08-07-2025
- Dividend Yield
- ANVS N/A
- BRNS N/A
- EPS Growth
- ANVS N/A
- BRNS N/A
- EPS
- ANVS N/A
- BRNS N/A
- Revenue
- ANVS N/A
- BRNS $14,969,000.00
- Revenue This Year
- ANVS N/A
- BRNS N/A
- Revenue Next Year
- ANVS N/A
- BRNS N/A
- P/E Ratio
- ANVS N/A
- BRNS N/A
- Revenue Growth
- ANVS N/A
- BRNS 1766.46
- 52 Week Low
- ANVS $1.11
- BRNS $0.64
- 52 Week High
- ANVS $10.54
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- ANVS 52.55
- BRNS 46.63
- Support Level
- ANVS $2.58
- BRNS $1.06
- Resistance Level
- ANVS $2.94
- BRNS $1.39
- Average True Range (ATR)
- ANVS 0.21
- BRNS 0.17
- MACD
- ANVS -0.00
- BRNS -0.04
- Stochastic Oscillator
- ANVS 64.41
- BRNS 30.51
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.